US$ 26.82
glucagon like peptide 1 glp 1 receptor agonist Effects of Glucagon-Like Peptide-1 Agonists on Diabetic Cardiomyopathy Glucagon-like peptide-1 receptor: mechanisms and
Description
India stands tall as the worlds pharmacy now poised to lead the GLP-1 revolution

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity

A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.

Compare early results with Wegovy and Mounjaro.

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.
